GeneCentrix

04/30/2021

Need to get back to work, but can't stop "testing" our latest version of HistoReceptomics 😂. It has improved features, interface and speed and makes and a whole lot easier. Register for your free trial here: https://historeceptomics.com

06/18/2020

GeneCentrix recognizes the holiday , commemorating the official end of slavery in the United States, and will be closed for company business tomorrow. We encourage our brother and sister companies in the and fields to recognize this holiday in any way they can and give their employees the opportunity to reflect on our collective struggle towards a better, more just society. We stand with all those who have been suffering injustice and with all people everywhere who are fighting for human rights and for the health and well-being of all world citizens.

06/03/2020

Join us tomorrow! Research Director, Dr. Jennifer Fuller, will discuss how our platform, , uses an elegant metric to rate chemical libraries by their suitability for phenotypic screens.

Explore the current state of computational methods used in phenotypic screening and novel in silico approaches, with discussions on deep learning, AI, functional genomics, chemical screening, systems biology, target deconvolution, biomarkers, and toxicity. Join us tomorrow: https://bit.nyas.org/2STTGN9

06/02/2020

Happy 20th to us! The 20th issue of our newsletter and blog, Attrition Zero (subscribe) is out. It’s on (duh): , , screens. Plus a cool we're sponsoring that you should really attend (more later). Happy reading:

COVID-19 continues to mature and consolidate into something which we can wrap our heads around better. One of the recent kerfuffles has been about the significance of a particular point mutation in the virus.  Is it a more contagious or dangerous form?

05/29/2020

FREE TRIAL: Try the Historeceptomics Tissue-Specific Drug Profiler FREE for 3 Weeks – The Historeceptomics Profiler can • Provide new insights into your drug’s mechanism of action • Reveal drug repositioning opportunities for you and • Uncover your drug's potential harmful side effects. Reduce your attrition rate today!

05/29/2020

Eureka! Our updated HistoReceptomics platform for , with even greater capability (tissue search) and looks (ahem) is almost ready to launch! Here's a sneak peak, available next week. Sign up ahead of time for a free trial: https://www.genecentrix.com/free-trial

05/28/2020

Time sure is funny under , but somehow the BIG DAY (or rather two days, June 4-5) that we have been planning and preparing for here at are almost here. Why are we excited? A little thing called . You see, our platform just happens to be perfectly suited to enhancing the efficiency of phenotypic screens by integrating and target expression into compound evaluation. So, we developed a simple (but we think very cool) metric to score chemical libraries according to their suitability for phenotypic screens. And now we will be presenting the work at a big ol' virtual put on by The New York Academy of Sciences: "Phenotypic Drug Discover: Leveraging Tools." So join us and folks from Pfizer, Princeton University, Massachusetts Institute of Technology (MIT), Columbia University in the City of New York, GlaxoSmithKline, Recursion Pharmaceuticals, MD Anderson Cancer Center and many others. It'll be a deep dive into , , functional , systems biology, chemical screening, target deconvolution, biomarkers, target deconvolution, toxicity and more! It's not too late to register now: https://bit.ly/2X7ZVza. Be there (virtually) and enter the future of with us!

Explore the current state of computational methods used in phenotypic screening and novel in silico approaches, and include discussions of deep learning, AI, functional genomics, chemical screening, systems biology, target deconvolution, biomarkers, and toxicity

05/13/2020

Join Olga Troyanskaya, other folks, from (Pfizer) to Academe (Columbia University in the City of New York)–and us!––for this rad exploration of cutting edge Screening, sponsored by the New York Academy of Sciences, N.Y.A.S. If you're into , or (think ), you won't want to miss this state-of-the-science discussion June 4-5. Register here today: https://bit.nyas.org/2STTGN9

Olga Troyanskaya, whose research centers around and functional genomics, will give a keynote talk at our “Phenotypic Drug Discovery” two-day virtual conference. Learn more and register here: https://bit.nyas.org/2STTGN9

05/06/2020

Advances in have led to a veritable deluge of , ironically SLOWING DOWN the process (oops). But a June at The New York Academy of Sciences will feature and solutions to the too-much-of-a-good-thing problem, including our very own , a powerful reducer and target enabler. Join us, Olga Troyanasaka of Princeton University and the Simons Foundation, Mike White, Ph.D. from Pfizer, and many more cool peeps–and don't miss our talk on Thursday, June 4 : "Historeceptomics Impoves the Yield of Phenotypic Screens."

Explore the current state of computational methods used in phenotypic screening and novel in silico approaches, and include discussions of deep learning, AI, functional genomics, chemical screening, systems biology, target deconvolution, biomarkers, and toxicity